| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10%+ Owner | $11,251,930 | 16 Aug 2021 | ||
| AI Biotechnology LLC | 10%+ Owner | $2,545,814 | 01 Nov 2023 | ||
| Andrew Saik | Chief Financial Officer | $265,547 | 28 May 2021 | ||
| Matthew T. Wiley | Chief Commercial Officer | $249,081 | 30 Jun 2021 | ||
| David Domzalski | PRESIDENT AND CEO, Director | $241,442 | 31 Dec 2025 | ||
| Patrick G. Lepore | Director | $150,298 | 12 Dec 2025 | ||
| Mutya Harsch | Chief Legal Officer And Gc | $73,037 | 31 Dec 2025 | ||
| Iain Stuart | Chief Scientific Officer | $66,850 | 31 Dec 2025 | ||
| Tyler Zeronda | Chief Financial Officer | $60,211 | 31 Dec 2025 | ||
| Elisabeth Sandoval Little | Director | 12 Dec 2025 | |||
| Sharon Barbari | Director | 12 Dec 2025 | |||
| Rex Bright | Director | 19 Jul 2021 | |||
| Anthony D. Bruno | Director | 12 Dec 2024 | |||
| Christine Borowski | Director | 12 Dec 2024 | |||
| Steven L. Basta | Director | 12 Dec 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| David Domzalski | VYNE | Common Stock | Tax liability | -2.96% | -12,684 | 416,208 | 31 Dec 2025 | Direct | ||
| Tyler Zeronda | VYNE | Common Stock | Tax liability | -7.04% | -7,858 | 103,795 | 31 Dec 2025 | Direct | ||
| Iain Stuart | VYNE | Common Stock | Tax liability | -2.08% | -2,448 | 115,239 | 31 Dec 2025 | Direct | ||
| Mutya Harsch | VYNE | Common Stock | Tax liability | -2.76% | -3,579 | 125,905 | 31 Dec 2025 | Direct | ||
| Elisabeth Sandoval | VYNE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 12 Dec 2025 | Direct | |||
| Patrick G. Lepore | VYNE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 12 Dec 2025 | Direct | |||
| Steven L. Basta | VYNE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 12 Dec 2025 | Direct | |||
| Sharon Barbari | VYNE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 12 Dec 2025 | Direct | |||
| Tyler Zeronda | VYNE | Common Stock | Tax liability | -2.97% | -3,420 | 111,653 | 30 Sep 2025 | Direct | ||
| Iain Stuart | VYNE | Common Stock | Tax liability | -2.04% | -2,453 | 117,687 | 30 Sep 2025 | Direct | ||
| Mutya Harsch | VYNE | Common Stock | Tax liability | -2.69% | -3,581 | 129,484 | 30 Sep 2025 | Direct | ||
| David Domzalski | VYNE | Common Stock | Tax liability | -2.87% | -12,676 | 428,892 | 30 Sep 2025 | Direct | ||
| Tyler Zeronda | VYNE | Common Stock | Tax liability | -2.89% | -3,420 | 115,073 | 30 Jun 2025 | Direct | ||
| Iain Stuart | VYNE | Common Stock | Tax liability | -2% | -2,453 | 120,140 | 30 Jun 2025 | Direct | ||
| Mutya Harsch | VYNE | Common Stock | Tax liability | -2.62% | -3,581 | 133,065 | 30 Jun 2025 | Direct | ||
| David Domzalski | VYNE | Common Stock | Tax liability | -2.79% | -12,676 | 441,568 | 30 Jun 2025 | Direct | ||
| Mutya Harsch | VYNE | Common Stock | Award | 0.85% | 1,145 | 136,646 | 02 Jun 2025 | Direct | ||
| David Domzalski | VYNE | Common Stock | Award | 1.95% | 8,681 | 454,244 | 02 Jun 2025 | Direct | ||
| Tyler Zeronda | VYNE | Common Stock | Tax liability | -6.62% | -8,399 | 118,493 | 31 Mar 2025 | Direct | ||
| Iain Stuart | VYNE | Common Stock | Tax liability | -4.7% | -6,044 | 122,593 | 31 Mar 2025 | Direct | ||
| Mutya Harsch | VYNE | Common Stock | Tax liability | -6.12% | -8,828 | 135,501 | 31 Mar 2025 | Direct | ||
| David Domzalski | VYNE | Common Stock | Tax liability | -6.41% | -30,498 | 445,563 | 31 Mar 2025 | Direct |